Dr. Ehrlich is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1 Dna Way Ms 454b
South San Francisco, CA 94080
Education & Training
Stanford Health Care-Sponsored Stanford UniversityResidency, Ophthalmology, 2005 - 2008
Santa Clara Valley Medical CenterInternship, Transitional Year, 2004 - 2005
Stanford University School of MedicineClass of 2004
Certifications & Licensure
CA State Medical License 2005 - 2026- American Board of Ophthalmology Ophthalmology
Publications & Presentations
PubMed
- 67 citationsEffects of intravitreal ranibizumab on retinal hard exudate in diabetic macular edema: findings from the RIDE and RISE phase III clinical trials.Amitha Domalpally, Michael S. Ip, Jason S. Ehrlich
Ophthalmology. 2015-04-01 - 104 citationsEfficacy of Every Four Monthly and Quarterly Dosing of Faricimab vs Ranibizumab in Neovascular Age-Related Macular Degeneration: The STAIRWAY Phase 2 Randomized Clinic...Arshad M. Khanani, Sunil S. Patel, Philip J. Ferrone, Aaron Osborne, Jayashree Sahni
JAMA Ophthalmology. 2020-09-01 - 140 citationsNeutralization of vascular endothelial growth factor slows progression of retinal nonperfusion in patients with diabetic macular edema.Peter A. Campochiaro, Charles C. Wykoff, Howard Shapiro, Roman G. Rubio, Jason S. Ehrlich
Ophthalmology. 2014-09-01
Press Mentions
SUBSPECIALTY NEWS: Port Drug Delivery in DME, Integrin Inhibitors, Treatment for XLRP, Eye Drops for DME, Gene Therapy, and MoreMarch 1st, 2020
Kodiak Sciences Announces Additional Safety, Efficacy and Durability Data from Ongoing Phase 1b Study of KSI-301 in Patients with Wet Age-Related Macular Degeneration, Diabetic Macular Edema and R...February 8th, 2020- SUBSPECIALTY NEWS: Stem-Cell Therapy for Geographic Atrophy, Artifacts in OCTA, European Opinion for Beovu, and MoreFebruary 1st, 2020
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
